$41.67 USD
Updated May 21 4:02pm
Add PFE to WatchlistTrade Grade Buy & Hold Grade Peer Grade Industry Rank
Ranked of 202 in Medical - Pharmaceuticals
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. The company was founded in 1849 and is based in New York, New York.
| Current price | $41.67 |
| Prev. close | $41.59 |
| Day low | $41.49 |
| Day high | $41.81 |
| 50-day MA | $41.44 |
| 200-day MA | $42.51 |
| 52-week high | $46.47 |
| 52-week low | $35.32 |
| Volume | 27,241,011 |
| Avg. volume | 24,335,420 |
| Dividend yield | 3.46% |
| Market Cap | 248.06B |
| 1-mo | 6.75% |
| 3-mo | -0.38% |
| 6-mo | -1.61% |
| 1-year | 20.39% |
| 3-year | 37.78% |
| 5-year | 67.96% |
| YTD | -2.85% |
| 2018 | 24.82% |
| 2017 | 15.90% |
| 2016 | 4.42% |
| 2015 | 7.09% |
| 2014 | 5.28% |
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...